Key facts
- Notable investors include Huayu Venture Capital, Huayu Win-Win (Beijing) Venture Capital Management, Lujiazui Asset Management, Roton Capital, Shulan Junjie Capital — 6 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 6 names
- ·Watchlist + deal alerts for Yinsheng Medical
- ·The full record, as it builds
Funding rounds
No funding rounds for Yinsheng Medical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Yinsheng Medical
Manufacturer of regenerative medical devices designed for tissue repair and cell therapy purposes. The company offers degradable medical membranes, stem cell therapy carriers, and multi-scale structural regulation technologies, enabling healthcare markets in oral restoration, reproductive health, medical aesthetics, and broader regenerative medicine fields to achieve improved tissue integration, enhanced biological safety, reduced variability in product performance, and more effective clinical translation of advanced regenerative therapies through systematic innovation and collaboration between academic research and clinical practice.
- Sector
- Healthcare
- HQ
- Hangzhou, China
- Founded
- 2022
- Ownership
- Privately Held (backing)
Yinsheng Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Yinsheng Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Yinsheng Medical in its N-PORT filings yet. We sweep new filings monthly.